Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/2811| Title: | Relative bioavailability and bioquivalence of three different oral formulations of Eslicarbazepine Acetate | Authors: | Nunes, Teresa Falcão, Amílcar Almeida, Luís Lima, Ricardo Tavares, Susana Neta, Carla Fontes-Ribeiro, Carlos Macedo, Tice Soares-da-Silva, Patricio |
Keywords: | eslicarbazepine acetate; bioequivalence; bioavailability | Issue Date: | 2005 | Publisher: | Blackwell Publishing, Inc.; International League Against Epilepsy | Citation: | NUNES, Teresa; et al. - Relative bioavailability and bioquivalence of three different oral formulations of Eslicarbazepine Acetate. Epilepsia, 46: Suppl. 8 (2005) 200. | Series/Report no.: | Abstract nr 2.325 | Abstract: | To investigate the bioavailability and bioequivalence of three formulations of eslicarbazepine acetate: 50 mg/mL oral suspension (Test 1), 200 mg tablets (Test 2) and 800 mg tablets (Reference) | Description: | AES Proceedings of the Annual Meeting of the American Epilepsy Society | URI: | https://hdl.handle.net/10316/2811 | Rights: | openAccess |
| Appears in Collections: | FFUC- Resumos em Livros de Actas |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| AES Proceedings - Epilepsia, 46(Suppl. 8), 1-3 C.pdf | 129.06 kB | Adobe PDF | View/Open |
Page view(s) 50
620
checked on Apr 16, 2024
Download(s)
146
checked on Apr 16, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.